Alpha-fetoprotein (AFP), one of the specific tumor markers for hepatocellular carcinoma, was below the normal level in most patients with ICC (n = 78, 73.6%), while CA19–9 was above the cut-off value in majority of patients (n = 73, 68.9%) included in the study. Here, AFP is linked to hepatocellular carcinoma.